Machado-Joseph disease (MJD), or spinocerebellar ataxia type 3 (SCA3), is a hereditary neurodegenerative disorder resulting from 56-84 consecutive glutamines in mutant ataxin-3; normal ataxin-3 has 14-37 consecutive glutamines. 1, 2 Mutant ataxin-3 is widely expressed, 3 causes neuronal loss in selective brain regions, 1 and has isoforms such as mjd1a that result from alternative splicing. 2 Neurotoxicity is associated with a critical concentration 4 of a mutant ataxin-3 putative-cleavage fragment containing the polyglutamine expansion. 5 It is controversial whether neurotoxicity is also associated with the formation of neuronal mutant ataxin-3 aggregate and intranuclear inclusions. [3] [4] [5] [6] Here, we used a mouse model of mutant ataxin-3 toxicity to examine whether such pathogenic markers occur in dying non-neuronal cells.
Our previously described transgenic mice (Q71-B and Q71-C homozygotes) 4 expressing human mutant ataxin-3 mjd1a under control of the mouse prion promoter have a phenotype resembling MJD and are infertile. Their heterozygous parents do not show MJD-like behavior and breed poorly (approximately 50% of the Q71-B and 25% of the Q71-C heterozygotes set up for breeding with wild-type mice have offspring). Transgenic mice expressing human wild-type ataxin-3 mjd1a (Q20-A) have normal behavior and fertility. 4 We now establish that the infertility in transgenic mice results from gonadal failure secondary to a neuroendocrine dysfunction and is not associated with the formation of mutant ataxin-3 putative-cleavage fragment or aggregate in gonadal cells.
Q71-B homozygotes had testicular atrophy, aspermia, and abundant apoptotic cells (Figure 1a and b) . Testes of Q71-B heterozygotes, Q20-A transgenic mice, and wild-type mice were similar (Figure 1a and b) , even at 12 months of age.
Mutant ataxin-3 mjd1a appeared localized to the nucleus and cytoplasm in testicular cells of Q71-B homozygotes and Q71-B heterozygotes ( Figure 1b ). The nuclear staining was mostly diffuse, with no inclusions comparable to those found in neurons of Q71-B homozygotes. 4 Human normal ataxin-3 mjd1a appeared enriched in the cytoplasm of testicular cells.
Homogenates of testes from Q71-B homozygotes and from Q71-B heterozygotes contained full-length mutant ataxin-3 mjd1a but not the cleavage fragment or aggregate previously detected in brain ( Figure 1c) . The other bands detected in testes of Q71-B homozygotes and heterozygotes were also present in homogenates of testes from Q20-A transgenic mice and therefore correspond to normal ataxin-3 or background bands.
Because the brain pathogenic markers were absent from testis, we examined whether testicular failure was secondary to deficient serum concentrations of gonadotropins: luteinizing (LH) or follicle stimulating (FSH) hormone (Table 1) . Both hormone concentrations in serum were low in male Q71-B homozygotes, when compared to wild-type mice. Male Q71-B heterozygotes had significantly low serum concentrations of FSH but not LH. The second line of Q71-B transgenic mice, Q71-C, had higher transgene expression levels, 4 lower fertility, abnormal testes (not shown) and low concentrations of gonadotropins in serum (Table 1) .
To determine whether the concentrations of other pituitary hormones in serum were abnormal in male Q71 homozygotes, we analyzed prolactin (PRL), thyroid stimulating hormone (TSH) and growth hormone (GH); only TSH concentrations were significantly lower in Q71 homozygotes than in wild-type mice ( Table 1) .
Females of both lines of Q71 transgenic mice had fertility problems and homogenates of their ovaries lacked the cleavage fragment and aggregate (not shown). Q71-B homozygotes had low LH, but not FSH, concentrations in serum when compared to wild-type mice ( Table 1 ). The serum concentrations of both hormones in Q71 heterozygotes and wild-type mice were not significantly different. Since the serum concentrations of gonadotropins in females vary with the estrus cycle, we analyzed prolactin (PRL), a hormone relevant to female but not male fertility. The PRL serum concentration was low in Q71 homozygotes, and not significantly different in Q71 heterozygotes, when compared to wild-type mice (Table 1) .
In summary, we found that infertile male transgenic mice expressing human mutant ataxin-3 mjd1a had testicular atrophy, aspermia, and abundant apoptotic testicular cells (Q71-B homozygotes) or were poorly fertile and had testes with normal morphology (Q71-B heterozygotes). Q20-A transgenic mice were normal. The testes from Q71-B homozygotes and heterozygotes lacked the mutant ataxin-3 mjd1a cleavage fragment and aggregate previously detected in their brain; 4 results in males of Q71 transgenic mice, Q71-C, were similar. Ovaries from infertile female Q71-B and Q71-C homozygotes also lacked the fragment and aggregate. We conclude that the infertility in Q71 transgenic mice is not Cells in sections (6 mm) of paraffin-embedded testes from perfused transgenic or wild-type mice, TUNEL-labeled (Roche Diagnostics, Pleasanton, CA) and counterstained with methyl green, or immunostained for ataxin-3 with antibody 144 (specific for residues 1-14) or 146 (specific for residues 320-334) and counterstained with hematoxylin using previously described procedures. 4 A few spermatozoids are highlighted (arrow). The magnification is the same for all images and is represented with a bar corresponding to 50 mm. (c) Western blot of homogenates (320 mg per lane) of testes and of brain from transgenic mice, revealed with ataxin-3 specific antiserum (a gift of Dr. H. Paulson, Department of Neurology, University of Iowa, Iowa City, IA). 3 Human mutant ataxin-3 aggregate (A), full-length form (FL), and cleavage fragment (F) are highlighted, as well as the full-length and smaller form of human normal ataxin-3 (n). Human and murine normal ataxin-3 co-migrated Letter to the Editor associated with the formation of mutant ataxin-3 mjd1a putative-cleavage fragment or aggregate in gonads. Q71 transgenic mice had low serum concentrations of several pituitary hormones including gonadotropins, indicating that they have a lesion in the hypothalamic-pituitary axis and their gonadal failure is secondary to this lesion, as reported for hypogonadotropic hypogonadism.
7 Q71-B homozygotes compared to Q71-B heterozygotes have a more severe phenotype and, as previously established, a higher concentration of mutant ataxin-3 mjd1a putative-cleavage fragment in brain cells. 4 Thus, a critical intracellular concentration of such fragment could be associated with neurotoxicity in the hypothalamic-pituitary axis of Q71 transgenic mice, as proposed for other brain regions of these transgenic mice and of MJD patients. 4 Whereas adenocorticotropic hormone deficiency has been reported in one MJD patient, 8 we found that all pituitary hormone concentrations in the serum of two male MJD patients were normal (unpublished results). Thus, the concentration of hormones in serum should be measured in a larger number of MJD patients to establish whether such patients have a neuroendocrine dysfunction and could benefit from hormonal therapy.
Testicular abnormalities were observed in transgenic mice expressing another polyglutamine protein, mutant huntingtin. 9 The concentrations of gonadotropins in their sera have not been determined. Such hormone measurements could be useful biomarkers of neuronal dysfunction.
